Sunshine Biopharma Inc (SBFM): According to the Breast Cancer Organizat...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Sunshine Biopharma Inc (SBFM)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	19
Posts	791
Boards Moderated	0
Alias Born	05/10/2009

Re: pennystockguru2011 post# 599

Monday, 11/28/2011 6:04:54 PM

Monday, November 28, 2011 6:04:54 PM

According to the Breast Cancer Organization of the USA, it is estimated that more than 260,000 new cases of breast cancer were diagnosed last year. The dreaded disease has rightfully never slipped from the spotlight, but has garnered stronger attention again with the latest news about Avastin®. By targeting drug-resistant cancer strains and outpacing Etoposide, Sunshine Biopharma's Adva-27 is right in the mix with other anti-cancer drugs in development. Just as Herceptin® revolutionized HER2 therapies for breast cancer - and generated nearly $7 billion in 2010 sales alone - Sunshine is looking to do the same with its Top2 drug in the future.

Go SBFM!

LW

Everything I write is my opinion only. My posts are not advice to be used for a investment decision.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent SBFM News

Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:05:31 PM
Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 03/05/2024 09:37:03 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:05:35 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/23/2024 09:03:01 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/21/2024 09:28:39 PM
Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 02/21/2024 01:24:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 10:01:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 04:39:32 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:53:03 PM
Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/14/2024 04:18:31 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/13/2024 05:15:10 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 09:05:15 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 02:04:50 PM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/09/2024 10:17:56 PM
Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/01/2024 09:17:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 05:38:24 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/08/2024 01:10:54 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:59:51 PM
Sunshine Biopharma Moves Principal Office to New York City • GlobeNewswire Inc. • 12/04/2023 01:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 02:00:15 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 01:00:46 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 04:18:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 05:06:33 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/19/2023 04:10:36 PM

More SBFM News

InvestorsHub NewsWire

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM

Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow